Catalyst Wire Dossier Catalyst Wire Dossier

Vascazen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vascazen, covering 2014-02-03 to 2014-02-03. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Study of Vascazen in Cardiac Rehab Patients With Deficient Blood Omega-3 Fatty Acid Levels [Phase 2]

See pricing